GLP-1 Access by StateMS

GLP-1 Weight Loss Medications in Mississippi

Navigate GLP-1 access in Mississippi — the state with the highest obesity rate faces unique coverage and access challenges.

Telehealth Prescribing

Allowed

Restrictions

Mississippi enacted SB 2640 (2021) making telehealth flexibilities permanent. Providers must hold a Mississippi license. Audio-video is required for initial encounters. Mississippi participates in the Interstate Medical Licensure Compact, which is critical given provider shortages.

Prescribing Rules

GLP-1 medications can be prescribed via telehealth in Mississippi after a video consultation. Mississippi does not require an in-person visit for non-controlled medications. The state has invested in telehealth infrastructure for the Delta region where provider shortages are most severe.

Insurance Coverage

Medicaid Coverage

Limited / Not expanded

Prior Authorization

Typically required

Major Insurers

Blue Cross Blue Shield of MississippiUnitedHealthcareHumanaMolina Healthcare

Mississippi has not expanded Medicaid. Traditional Medicaid covers only very low-income parents (below 27% FPL), pregnant women, children, and disabled individuals. An estimated 100,000 Mississippians are in the coverage gap. Mississippi has the highest adult obesity rate in the nation at approximately 41%. The combination of high need and limited coverage creates a significant access crisis for GLP-1 medications.

Cost Breakdown

Brand Name

$900-$1400

per month, without insurance

Compounded

Available

$200-$450

per month

Top Providers in Mississippi

Ro

Telehealth

Serves Mississippi residents with compounded semaglutide; critical for Delta and rural communities.

UMMC Weight Management (Jackson)

In-Person

University of Mississippi Medical Center is the state only academic medical center with obesity medicine.

Hims & Hers

Telehealth

Compounded semaglutide delivery to all Mississippi ZIP codes.

The Mississippi Obesity Crisis

Mississippi has the highest adult obesity rate in the nation at approximately 41%, with some Delta counties exceeding 50%. Type 2 diabetes, heart disease, and other obesity-related conditions are correspondingly high. This creates enormous demand for GLP-1 medications, but the state lack of Medicaid expansion and limited provider availability means that those who need treatment most often cannot access it. Telehealth and compounded medications offer the most scalable solution to this access crisis.

The Medicaid Gap

Mississippi has not expanded Medicaid and has one of the strictest eligibility thresholds in the country — parents must earn below 27% of the federal poverty level to qualify. This means a working parent earning more than roughly $6,300/year does not qualify for Medicaid but likely earns too little for marketplace subsidies. An estimated 100,000 Mississippians fall in this gap. For these residents, compounded semaglutide at $200-$450/month through telehealth is the primary GLP-1 access pathway.

Delta Region Access

The Mississippi Delta is one of the most medically underserved regions in the United States. Multiple hospitals have closed, and many counties have no physician at all. Telehealth platforms are essential for connecting Delta residents with obesity medicine providers. Mississippi investment in broadband expansion is gradually improving connectivity, but satellite internet and cellular data remain the only options in some areas.

Mississippi has the highest adult obesity rate nationally (~41%)
Delta counties face severe provider shortages and hospital closures
Telehealth and compounded medications are the most scalable access solutions

FAQ

Frequently Asked Questions

Mississippi has not expanded Medicaid. Traditional Medicaid has very strict eligibility (below 27% FPL for parents). Those who qualify can get GLP-1 coverage for diabetes. Approximately 100,000 Mississippians are in the coverage gap.

Mississippi has the highest adult obesity rate in the nation at ~41%. The combination of high need, no Medicaid expansion, and severe provider shortages creates a significant public health crisis that GLP-1 medications could help address.

Yes. Mississippi allows telehealth prescribing after a video consultation. Platforms like Ro and Hims & Hers serve all Mississippi ZIP codes including the Delta, though broadband access can be a barrier in some areas.

Compounded semaglutide costs $200-$450/month through telehealth platforms. Brand-name Wegovy costs $900-$1,400/month. For uninsured Mississippians, compounded options are often the only affordable pathway.